K
Keita Wada
Researcher at Teikyo University
Publications - 110
Citations - 7383
Keita Wada is an academic researcher from Teikyo University. The author has contributed to research in topics: Pancreatic cancer & Pancreatitis. The author has an hindex of 44, co-authored 106 publications receiving 5754 citations.
Papers
More filters
Journal ArticleDOI
Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines
Keita Wada,Tadahiro Takada,Yoshifumi Kawarada,Yuji Nimura,Fumihiko Miura,Masahiro Yoshida,Toshihiko Mayumi,Steven M. Strasberg,Henry A. Pitt,Thomas R. Gadacz,Markus W. Büchler,Jacques Belghiti,Eduardo de Santibañes,Dirk J. Gouma,Horst Neuhaus,Christos Dervenis,Sheung Tat Fan,Miin Fu Chen,Chen Guo Ker,Philippus C. Bornman,Serafin C. Hilvano,Sun Whe Kim,Kui Hin Liau,Myung-Hwan Kim +23 more
TL;DR: New criteria for the diagnosis and severity assessment of acute cholecystitis are proposed,Based on a systematic review of the literature and a consensus of experts, based on the best current available evidence.
Journal ArticleDOI
Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis.
Kohji Okamoto,Kenji Suzuki,Tadahiro Takada,Steven M. Strasberg,Horacio J. Asbun,Itaru Endo,Yukio Iwashita,Taizo Hibi,Henry A. Pitt,Akiko Umezawa,Koji Asai,Ho-Seong Han,Tsann Long Hwang,Yasuhisa Mori,Yoo Seok Yoon,Wayne Shih Wei Huang,Giulio Belli,Christos Dervenis,Masamichi Yokoe,Seiki Kiriyama,Takao Itoi,Palepu Jagannath,O. James Garden,Fumihiko Miura,Masafumi Nakamura,Akihiko Horiguchi,Go Wakabayashi,Daniel Cherqui,Eduardo de Santibañes,Satoru Shikata,Yoshinori Noguchi,Tomohiko Ukai,Ryota Higuchi,Keita Wada,Goro Honda,Avinash Supe,Masahiro Yoshida,Toshihiko Mayumi,Dirk J. Gouma,Daniel J. Deziel,Kui Hin Liau,Miin Fu Chen,Kazunori Shibao,Keng Hao Liu,Cheng Hsi Su,Angus C.W. Chan,Dong Sup Yoon,In Seok Choi,Eduard Jonas,Xiao Ping Chen,Sheung Tat Fan,Chen Guo Ker,Mariano E Giménez,Seigo Kitano,Masafumi Inomata,Koichi Hirata,Kazuo Inui,Yoshinobu Sumiyama,Masakazu Yamamoto +58 more
TL;DR: In the Tokyo Guidelines 2018 (TG18) as discussed by the authors, the authors proposed a flowchart for the treatment of acute cholecystitis (AC) in advanced centers with specialized surgeons experienced in this procedure.
Journal ArticleDOI
Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines
Yasutoshi Kimura,Tadahiro Takada,Yoshifumi Kawarada,Yuji Nimura,Koichi Hirata,Miho Sekimoto,Masahiro Yoshida,Toshihiko Mayumi,Keita Wada,Fumihiko Miura,Hideki Yasuda,Yuichi Yamashita,Masato Nagino,Masahiko Hirota,Atsushi Tanaka,Toshio Tsuyuguchi,Steven M. Strasberg,Thomas R. Gadacz +17 more
TL;DR: Variations in treatment and risk factors influencing the mortality rates indicate the necessity for standardized diagnostic, treatment, and severity assessment criteria on acute cholecystitis and cholangitis.
Journal ArticleDOI
Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015.
Masamichi Yokoe,Tadahiro Takada,Toshihiko Mayumi,Masahiro Yoshida,Shuji Isaji,Keita Wada,Takao Itoi,Naohiro Sata,Toshifumi Gabata,Hisato Igarashi,Keisho Kataoka,Masahiko Hirota,Masumi Kadoya,Nobuya Kitamura,Yasutoshi Kimura,Seiki Kiriyama,Kunihiro Shirai,Takayuki Hattori,Kazunori Takeda,Yoshifumi Takeyama,Morihisa Hirota,Miho Sekimoto,Satoru Shikata,Shinju Arata,Koichi Hirata +24 more
TL;DR: Japanese (JPN) guidelines for the management of acute pancreatitis were published in 2006, and following the 2012 revision of the Atlanta Classifications of Acute Pancreatitis, the development of a minimally invasive method for local complications of pancreatitis spread was developed.
Journal ArticleDOI
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)
Fuyuhiko Motoi,Tomoo Kosuge,Hideki Ueno,Hiroki Yamaue,Sohei Satoi,Masayuki Sho,Goro Honda,Ippei Matsumoto,Keita Wada,Junji Furuse,Yutaka Matsuyama,Michiaki Unno +11 more
TL;DR: A randomized, controlled trial has begun to compare neoadjuvant chemotherapy using gemcitabine and S-1 with upfront surgery for patients planned resection of pancreatic cancer.